Serum miRNA expression profiles change in autoimmune vitiligo in mice.

Exp Dermatol

Henry Ford Immunology Program, Henry Ford Hospital, Detroit, MI, USA; Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA; Department of Dermatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Published: February 2014

It is widely believed that non-segmental vitiligo results from the autoimmune destruction of melanocytes. MicroRNAs (miRNAs), a class of small non-coding RNAs that negatively regulate gene expression, are involved in the immune cell development and function and regulate the development of autoimmune diseases. Recent studies demonstrate that functional miRNAs can be detected in the serum and serve as biomarkers of various diseases. In the present study, we used a mouse autoimmune vitiligo model, in which melanocyte autoreactive CD4+ T cells were adoptively transferred into Rag1(-/-) host mice. Serum miRNA expression was profiled in vitiligo developed mice and control mice using TaqMan RT-PCR arrays. We have found that the expressions of 20 serum miRNAs were changed in vitiligo mice compared to control mice. Three increased miRNAs, miR-146a, miR-191, and miR-342-3p, were further confirmed by a single TaqMan RT-PCR. Our findings suggest that miRNAs may be involved in vitiligo development and serum miRNAs could serve as serum biomarkers for vitiligo in mice.

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.12319DOI Listing

Publication Analysis

Top Keywords

vitiligo mice
12
serum mirna
8
mirna expression
8
autoimmune vitiligo
8
control mice
8
taqman rt-pcr
8
serum mirnas
8
vitiligo
7
mice
7
serum
6

Similar Publications

Mechanistic Insights into the Stimulatory Effect of Melanogenesis of 4-Methylcoumarin Derivatives in B16F10 Melanoma Cells.

Int J Mol Sci

November 2024

Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea.

Vitiligo is a skin condition characterized by the loss of pigment, resulting in white patches on various parts of the body. It occurs when melanocytes, the cells that are responsible for producing skin pigment, are destroyed or stop functioning. This study aimed to investigate the melanogenic potential of various 4-methylcoumarin (4MC) derivatives, including 6-methoxy-4-methylcoumarin (6M-4MC), 7-methoxy-4-methylcoumarin (7M-4MC), 7-amino-4-methylcoumarin (7A-4MC), 6,7-dihydroxy-4-methylcoumarin (6,7DH-4MC), 7,8-dihydroxy-4-methylcoumarin (7,8DH-4MC), and 6,7-dimethoxy-4-methylcoumarin (6,7DM-4MC), in B16F10 melanoma cells.

View Article and Find Full Text PDF

Vitiligo is the most common cause of depigmentation worldwide, with immunosuppressive treatments often being inefficient and prone to recurrence, making it essential to identify new therapeutic targets. Periplakin (PPL) has been identified and confirmed as a key factor in vitiligo-related depigmentation. Based on this, a series of selective PPL agonists, specifically benzenesulfonamides, have been developed.

View Article and Find Full Text PDF

Lighting up arginine metabolism reveals its functional diversity in physiology and pathology.

Cell Metab

October 2024

Optogenetics & Synthetic Biology Interdisciplinary Research Center, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China; Research Unit of New Techniques for Live-cell Metabolic Imaging, Chinese Academy of Medical Sciences, Beijing 100730, China. Electronic address:

Article Synopsis
  • * The researchers developed high-performance fluorescent biosensors called sensitive to arginine (STAR) that allow for real-time monitoring of arginine levels in cells, mice, and clinical samples.
  • * Using STAR, they discovered the influence of different amino acids on arginine levels and found that serum arginine levels tend to rise with age, which could help in assessing the progression of conditions like vitiligo.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of oxidative stress and IFNγ-driven immune responses in the development of vitiligo, focusing on how mast cells produce IFNγ and its effects on the disease progression.* -
  • Researchers analyzed skin samples from vitiligo patients and used a mouse model to explore how stress signals (like hydrogen peroxide) affect the recruitment of mast cells and CD8+ T cells to affected skin areas.* -
  • Results showed that IFNγ-producing mast cells increased alongside CD8+ T cells in early vitiligo, suggesting that skin stress leads to changes in immune cell dynamics, which may contribute to the pathogenesis of vitiligo.*
View Article and Find Full Text PDF

Many autologous melanocytes are required for surgical treatment of depigmentation diseases such as vitiligo. However, primary cultured melanocytes have a limited number of in vitro passages. The production of functional epidermal melanocytes from stem cells provides an unprecedented source of cell therapy for vitiligo.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!